Cisanello Hospital, Pisa Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2016
NCT03425630
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Endrinology Unit 1; Cisanello Hospital, Pisa (Italy)

Active Ingredients

Drugs in Other Trials (2)

gemfibrozil (lopid) (1 trial)

monascus garlic fermented extract (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2